HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance

Hepat Oncol. 2020 Jun 22;7(2):HEP21. doi: 10.2217/hep-2020-0010.
No abstract available

Keywords: DAA; HCC; HCV; biomarkers; direct-acting antiviral.

Publication types

  • Editorial